Tobacco related disease;Pathologie liée au tabagisme

Revue du Praticien

Volumn 54, Issue 17, 2004, Pages 1877-1882

  Dautzenberg, Bertrand ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADOLESCENT; ADULT; BLADDER CARCINOMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; ESOPHAGUS CANCER; FEMALE; HEART DEATH; HEART INFARCTION; HISTIOCYTOSIS X; HUMAN; KIDNEY CANCER; LARYNX CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHARYNX CANCER; PREGNANCY; REVIEW; RISK FACTOR; STROKE; SUDDEN DEATH; TOBACCO;

CARDIOVASCULAR DISEASES; DEATH, SUDDEN; FEMALE; HUMANS; MALE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 9444265252     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull 1996; 52: 12-2.
2. U.S. department of health and human services, National Cancer Institute. Changes in cigarette-related disease risks and their implication for prevention and control. National Institutes of Health. N.I.H. Publication No. 97-4213. Washington, D.C., 1997.
3. Dautzenberg B. Tabagisme passif. Rapport du groupe de travail DGS. Paris: La documentation française, DGS, 2001.
4. Hill C. L'arrêt de la consommation du tabac. Paris: EDK, 1998: 67-75.
5. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976; 25: 1525-36.
6. SPLF. Actualisation 2003 des recommandations de la SPLF sur la prise en charge de la BPCO: organisation et argumentaire. Rev Mal Respir 2003; 20: 7-68.
7. Tashkin OP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest 2004; 125: 249-59.
8. De Marco R, Accordini S, Cerveri I et al. European Community Respiratory Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004; 59: 120-5.
9. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-8.
10. Kazerouni N, Alverson CJ, Redd SC, Mott JA, Mannino DM. Sex differences in COPD and lung cancer mortality trends-United States, 1968-1999. J Womens Health 2004; 13: 17-23.
11. Haldorsen T, Andersen A, Boffetta P. Smokinq-adjusted incidence of lung cancer by occupation among Norwegian men. Cancer Causes Control 2004; 15: 139-47.
12. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004; 291: 1763-8.
13. Blanchon F, Grivaux M, Breton JL. Cancer du poumon chez la femme en 2000: Résultat d'une étude épidémioloqique (KBP-2000). Rev Pneumol Clin 2003; 59: S56-S58.
14. Au JS, Mang OW, Foo W, Law SC. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000. Lung Cancer 2004; 45: 143-52.
15. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321: 323-9.
16. Videtic GM, Stitt LW, Dar AR et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003; 21: 1544-9.
17. Shinton R, Beevers G. Metaanalysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-94.
18. Myers AH. Smoking behavior among participants in the nurses' health study. Am J Public Health 1987; 77: 628-30.
19. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001; 357: 995-1001
20. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000; 160: 939-44.
21. Marchand G. Épidémiologie et facteurs de risque de l'artérite oblitérante des membres inférieurs. Ann Cardiol Angeiol 2001; 50: 119-27.
22. rd. Passive smoking, coronary heart disease, and metaanalysis. N Engl J Med 1999; 340: 958-9.
23. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease - a metaanalysis of epidemiologic studies. N Engl J Med 1999; 340: 920-6.
24. Thun M, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect 1999; 107: 841-6.
25. De Mouzon J. Tabac et Fertilité, Tabac et PMA. Rev Prat Gynecol Obstetr 2001; 55: 34-8.
26. Delcroix M, Chuffart M. Grossesse et tabac. Paris: PUF Collection «Que Sais-je?», 2004; n° 3490.
27. Fogelman K, Manor O. Smoking in pregnancy and development into early adulthood. BMJ 1988; 297: 1233-6.
28. Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2001; 154: 322-7.